Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Using visual support technology powered by TechSee, Cochlear has been able to bolster their customer experience by focusing on the needs of recipients through the use of Augmented Reality. NEW YORK, ...

In a report released on February 14, David Low from J.P. Morgan upgraded Cochlear Limited (CHEOF – Research Report) to a Buy, with a price target of A$311.00. The company’s shares closed last Friday ...

Jefferies analyst David Stanton maintained a Hold rating on Cochlear Limited (CHEOF – Research Report) today and set a price target of A$304.00. The company’s shares closed yesterday at $232.96.

LONE TREE, Colo., June 2, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 ...

Cochlear Limited ((CHEOF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...